| Course | DNP 965A DPI Project: Part III |
|---|---|
| Topic | Topic 8 |
| Paper type | Final defense preparation paper |
| Length | About 1,090 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | September 2026 |
Free sample paper for DNP 965A Topic 8
One Line From Problem to Claim, Checked Link by Link: Preparing to Defend a Statin Outreach DPI Project, Including Its Weakest Link
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-965A: DPI Project: Part III
Topic 8 Assignment
[Instructor Name]
May 6, 2030
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
One Line From Problem to Claim, Checked Link by Link: Preparing to Defend a Statin Outreach DPI Project, Including Its Weakest Link
The Argument in One Line
The final report is 42 pages long, assembled across five courses. A committee will not examine it chapter by chapter; it will test whether the argument holds. Stated as one line, the argument is this: too few of the network's diabetic patients in their forties and early fifties were on the statin the guidelines call for; statins prevent cardiovascular events in people with diabetes; calls from nurse care managers, built around a decision aid and ending in an order pended for signature, were chosen to close it; one fixed group was measured before the outreach and again after it; and statin use climbed 9.6 points, mostly among the people the care managers actually spoke with. Each link is checked below for whether it actually holds.
Checking Each Link
The problem holds. The gap was measured three times as the definition was tightened, from 58 percent in 2027 to a corrected 57 percent in the managed population, and the report explains every change (report pages 6 to 9, Table 1).
The evidence that the problem matters holds strongly. Statins reduce major vascular events in people with diabetes by about a fifth per unit of LDL reduction (Cholesterol Treatment Trialists' Collaborators, 2008), and the national standards recommend them for this age group without a separate risk calculation (American Diabetes Association Professional Practice Committee, 2025) (report pages 10 and 11).
The choice of intervention holds partly. The prescriber-facing part, the pended order, rests on trial evidence that clinician nudges raise prescribing and patient nudges alone may not (Adusumalli et al., 2023). The outreach call itself has weaker support in a setting like this one, which the literature review said and which led to the feasibility phase (report pages 12 to 15).
The comparison holds within its limits. The same 912 patients were measured before and after, with a prespecified test and threshold, but there was no concurrent control (report pages 22 to 25, Table 4).
The claim holds only in its bounded form. The rise is real and exceeds the prespecified threshold, but part may reflect added prescriber time and the winter season (report pages 28 to 31).
Four Questions a Committee Member Will Ask
"Why measure orders and fills rather than whether patients are actually taking statins, or their LDL?" Because the data support nothing more. Pharmacy fills are visible for only about three in five patients and cholesterol is rarely checked at this age, so a question about adherence or LDL would have promised an answer the data could not give. The report says the finding is about prescribing, not protection (report page 17, the tightened question; page 32, limitation 6).
"Why compare September to February with the months before, when the seasons differ?" Because the network's schedule and the care managers' capacity fixed the implementation period, and the baseline had to precede it. The report states the seasonal difference as its second most serious limitation and gives an approximate size for it from the older, unreached group, 1.4 points over the same months (report page 27, exploratory comparison; page 33, ranking of limitations).
"Why did muscle symptom contacts nearly double among new starters?" The honest answer is that the project cannot say. The rise from 7.4 to 13.8 percent was not statistically detectable with 54 baseline starters, and it never reached the 15 percent line the plan had set in advance as a sign of harm. Two explanations are plausible: care managers told every new starter to call about muscle aches, which may have increased reporting rather than symptoms, and outreach may have started statins in patients who were more hesitant and more attentive to side effects. The report gives the measure the same space as the primary outcome and does not explain it away (report page 24, Table 5).
"Given a result of this size, what should the network do?" Keep the daytime outreach and the standing protocol, which cost about seven care manager hours a month and are already handed over; consider extending the protocol to older patients outside the Medicare Advantage program; and decide whether to fund the evening calls, which the project could not sustain. It should not expect the same size of effect if the outreach shrinks toward the easiest patients, and the dashboard measure will show whether it does (report pages 36 to 40, handover plan and dissemination plan).
The Weakest Link, Named First
The weakest link is the step from comparison to claim: attributing the rise to the outreach rather than to the concurrent staffing change. The staffing change happened in the same months, affected the same patients and would raise statin use in the same way, and among patients who were phoned and also visited more, no data can tell the two influences apart. A single-group before-and-after design cannot exclude a concurrent event of this kind (Shadish et al., 2002). I will name this weakness in the first five minutes of the defense rather than wait to be asked, and I will point to the two pieces of evidence that bound it: the older group that no one called gained just 1.4 points across those months, and only 11 of the 130 patients who started a statin did so without being reached. That does not remove the weakness. It shows the committee I know where the argument is thinnest and how thin it is.
If a committee member asks what would have removed the weakness, the answer is a stepped start: launching outreach in three clinics in September and the other three in December would have given two months in which some clinics had outreach and others had only the added prescribers. The network's requirement of a simultaneous start ruled that out, and the report records it as the design the next project should try to negotiate.
Preparation for the defense itself follows the same line. I will rehearse the one-line argument aloud until it takes under a minute, keep Table 4 and Table 5 on a single printed page for quick reference, and ask two colleagues to play the most skeptical committee member, one pressing on the staffing overlap and one on the muscle symptom signal. Any question they raise that the report cannot answer from its own pages will be listed, with the page where the answer should have been, so the gap is closed before the committee finds it.
References
Adusumalli, S., Kanter, G. P., Small, D. S., Asch, D. A., Volpp, K. G., Park, S. H., Gitelman, Y., Do, D., Leri, D., Rhodes, C., VanZandbergen, C., Howell, J. T., Epps, M., Cavella, A. M., Wenger, M., Harrington, T. O., Clark, K., Westover, J. E., Snider, C. K., & Patel, M. S. (2023). Effect of nudges to clinicians, patients, or both to increase statin prescribing: A cluster randomized clinical trial. JAMA Cardiology, 8(1), 23-30. https://doi.org/10.1001/jamacardio.2022.4373
American Diabetes Association Professional Practice Committee. (2025). 10. Cardiovascular disease and risk management: Standards of care in diabetes-2025. Diabetes Care, 48(Suppl. 1), S207-S238. https://doi.org/10.2337/dc25-S010
Cholesterol Treatment Trialists' Collaborators. (2008). Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. The Lancet, 371(9607), 117-125. https://doi.org/10.1016/S0140-6736(08)60104-X
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi-experimental designs for generalized causal inference. Houghton Mifflin.
Reading the GCU DNP 965A Topic 8 instructions
The final topic of DNP-965A asks the student to get ready to present and defend the completed project. The instructions look for a summary of the project as a coherent argument, the questions a committee is likely to ask, prepared answers grounded in the report and an honest account of the project's limits. It is a preparation document, so it is written for the student and the chair rather than for publication, and it should point to where in the final report each answer can be found. The best preparation treats the defense as a test of reasoning, not as a recital of chapters written across earlier courses.
How the DNP-965A Topic 8 example is put together
The finished example is an argument rather than a set of chapters bound together. The problem, the evidence for it, the intervention chosen, the comparison run and the claim reached appear as one line, and each link is checked to see whether it actually holds. Four anticipated questions follow, each written as a committee member would ask it: why this outcome, why this comparison period, why the secondary measure moved, and what the site should do given a result of this size. Each answer names the page and the table it rests on. The weakest link is identified by the writer rather than left for a panel to find, and the prepared response concedes rather than defends.
DNP 965A Topic 8 rubric: what Excellent looks like
GCU faculty grading this topic look first at whether the project is stated as one argument that can be checked. The Excellent level goes to preparation that tests each link from problem to claim and grades it honestly rather than calling every link strong. Anticipated questions earn credit when they are phrased the way a committee would ask them and answered with located evidence, down to the page and the table. The rubric rewards disclosure: naming the weakest point first, bounding it with data and saying what design would have removed it. Rehearsal plans, such as timed practice with colleagues playing skeptical members, show readiness beyond the written answers.
Common DNP 965A Topic 8 mistakes, and how to avoid them
A defense assembled as a summary of chapters, rather than as an argument, struggles hardest under questioning, because nothing in it explains why one section leads to the next. A second failure is rehearsing only the comfortable questions, which leaves the difficult one to be met without any preparation at all. Marks also go for answers with no located evidence, since a committee asking where a figure came from expects a table rather than a recollection. Claims restated more strongly under pressure lose a room quickly. Weak points left for the panel to find set the tone for everything after. Preparation unable to say what the project failed to establish will be asked twice.
Get a DNP-965A Topic 8 example written to your instructions
Send the DNP-965A Topic 8 assignment instructions and the rubric your classroom posts, with any defense format your section requires. We write a custom example to those criteria, with the argument carried in one line, the weakest link named and four questions rehearsed, in 24 to 48 hours. The first one is free.
More DNP 965A papers and DNP samples
- DNP 965A Topic 1: Prespecified Analysis Report
- DNP 965A Topic 2: Results Write-up
- DNP 965A Topic 3: Bounded Interpretation Section
- DNP 965A Topic 4: Limitations Statement
- DNP 965A Topic 5: Null Result DQ Pair
- DNP 965A Topic 6: Sustainability Handover Plan
- DNP 965A Topic 7: Dissemination Plan
- DNP 960A Topic 8: Plan Revision Report
- DNP 801A Topic 8: Readiness Statement
- DNP 955 Topic 8: Proposal Assembly and Consistency Pass
- DNP 805 Topic 8: Informatics Governance Analysis
DNP 965A Topic 8 questions, answered
Should I name my own weakest point?
Yes, and early. A committee locates it regardless, and the difference between a disclosure and a discovery is the difference between a discussion and a cross-examination. Naming it first also lets the writer frame what it costs the claim, which is a judgment the panel would otherwise make alone and usually less generously.
What does a committee actually press on?
In many defenses, the join between the problem and the intervention chosen, the comparability of the two periods, and any outcome that moved unexpectedly. Those are the places where an argument commonly rests on an assumption nobody stated aloud. Rehearsing them in the phrasing a panel would use beats rehearsing a summary of the work.
Do you prepare my defense or write my project?
Neither. The project is your doctoral work, the data and the analysis are yours, and the review submission and any site agreement were issued to you and stay with you. A sample shows how a finished argument is assembled from work already done: how links are tested, how a weak point is disclosed, how questions are located.
Where can I find a free DNP 965A Topic 8 sample paper?
The complete defense preparation paper is on this page, from the one-line argument and the link-by-link check to four committee questions and the weakest link. A model built around your own completed project is available free on request.
How long is the DNP 965A Topic 8 defense preparation example?
About 1,090 words across three pages in APA 7 form, with four references. Length matters less than coverage here: every link in the argument is checked and every anticipated question points to a page in the final report.